FDA publishes tougher standards for COVID-19 vaccines

FDA publishes tougher standards for COVID-19 vaccines

The White House has approved more stringent FDA standards for Emergency Use Authorization of COVID-19 vaccines after the FDA published the standards as part of a briefing for an advisory panel of vaccine experts. Vaccine developers will need two months of follow-up data from at least 50% of trial participants after the final dose is administered, meaning there is unlikely to be any EUA before the end of November.

Full Story: NBC News (10/6),  The Washington Post (tiered subscription model) (10/6)